Analysis of sialyllactoses in blood and urine by high-performance liquid chromatography

被引:17
作者
Fu, DT [1 ]
Zopf, D [1 ]
机构
[1] Neose Technol Inc, Horsham, PA 19044 USA
关键词
oligosaccharides; sialyllactose; 1-phenyl-3-methyl-5-pyrazolone; PMP; HPLC; biological fluids; urine; blood plasma;
D O I
10.1006/abio.1998.3021
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A sensitive and highly selective high-performance liquid chromatography (HPLC)-based method has been developed for the analysis of oligosaccharides in biological fluids. In this method, a sample of biological fluid, such as blood serum or urine, is filtered through a 10,000 molecular weight cutoff filter cartridge to remove large molecules such as proteins and lipids. The carbohydrates in the filtrate are then derivatized with 1-phenyl-3-methyl-5-pyrazolone (PMP) as described previously [Anal. Biochem. 180, 351-357, (1989)]. The derivatized carbohydrates are separated by reverse-phase HPLC and monitored by UV absorbance at 245 nm. Quantitative analysis of the carbohydrates can be achieved based on their integration values relative to a standard calibration curve. Since neutral and acidic carbohydrates can be separated by using Dowex 1-X8 anion exchange resin, this method can be used specifically to analyze neutral, acidic, and total carbohydrates in the biological fluids. Because PMP specifically reacts with reducing aldoses, interference from noncarbohydrate components present in the biological fluids is essentially eliminated. This method has proven to be highly sensitive, requiring as little as 5 pmol of analyte for reliable analysis. It has also been used successfully for pharmacokinetic analysis of carbohydrate drugs in human blood and urine samples. (C) 1999 Academic Press.
引用
收藏
页码:113 / 123
页数:11
相关论文
共 50 条
  • [1] Analysis of urine for cysteine, cysteinylglycine, and homocysteine by high-performance liquid chromatography
    Kusmierek, K.
    Glowacki, R.
    Bald, E.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2006, 385 (05) : 855 - 860
  • [2] Analysis of urine for cysteine, cysteinylglycine, and homocysteine by high-performance liquid chromatography
    K. Kuśmierek
    R. Głowacki
    E. Bald
    Analytical and Bioanalytical Chemistry, 2006, 385 : 855 - 860
  • [3] Detection of synthetic corticosteroids in bovine urine by chemiluminescence high-performance liquid chromatography
    Vászquez, BI
    Feás, X
    Lolo, M
    Fente, CA
    Franco, CM
    Cepeda, A
    LUMINESCENCE, 2005, 20 (03) : 197 - 204
  • [4] DETERMINATION OF FAMOTIDINE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    CVITKOVIC, L
    ZUPANCICKRALJ, L
    MARSEL, J
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1991, 9 (02) : 207 - 210
  • [5] Determination of Cotinine in Human Urine by High-Performance Liquid Chromatography
    Wen, Yen-Hsia
    Yang, Pei-Shin
    Wu, Shihn-Sheng
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2009, 17 (05) : 357 - 362
  • [6] Simultaneous determination of purine metabolites in ovine urine and blood plasma by high-performance liquid chromatography
    Czauderna, M
    Kowalczyk, J
    JOURNAL OF ANIMAL AND FEED SCIENCES, 2004, 13 : 55 - 58
  • [7] DETERMINATION OF PENTAMIDINE IN WHOLE-BLOOD, PLASMA, AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    ERICSSON, O
    RAIS, M
    THERAPEUTIC DRUG MONITORING, 1990, 12 (04) : 362 - 365
  • [8] Determination of pimethixene in plasma and urine by high performance liquid chromatography
    Kountourellis, JE
    Ebete, KO
    ANALYTICAL LETTERS, 1996, 29 (05) : 775 - 784
  • [9] Determination of linezolid in human serum and urine by high-performance liquid chromatography
    Borner, K
    Borner, E
    Lode, H
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (03) : 253 - 258
  • [10] Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometry
    Leung, Kit-Yi
    Mills, Kevin
    Burren, Katie A.
    Copp, Andrew J.
    Greene, Nicholas D. E.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2011, 879 (26): : 2759 - 2763